SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0000950116-05-000924
Filing Date
2005-03-07
Accepted
2005-03-07 16:30:46
Documents
3

Document Format Files

Seq Description Document Type Size
1 POS.TXT pos.txt POS AM 64258
2 EX23-1.TXT ex23-1.txt EX-23 815
3 EX23-2.TXT ex23-2.txt EX-23 663
  Complete submission text file 0000950116-05-000924.txt   67463
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-121309 | Film No.: 05664321
SIC: 2834 Pharmaceutical Preparations